149 related articles for article (PubMed ID: 29596469)
1. Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.
Thierauf J; Weissinger SE; Veit JA; Affolter A; Laureano NK; Beutner D; Heiduschka G; Kadletz L; Meyer M; Quaas A; Plinkert P; Hoffmann TK; Hess J
PLoS One; 2018; 13(3):e0194989. PubMed ID: 29596469
[TBL] [Abstract][Full Text] [Related]
2. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
4. Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck.
Wolf GT; Winter W; Bellile E; Nguyen A; Donnelly CR; McHugh JB; Thomas D; Amlani L; Rozek L; Lei YL;
Oral Oncol; 2018 Dec; 87():29-35. PubMed ID: 30527240
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients.
Nijkamp MM; Span PN; Hoogsteen IJ; van der Kogel AJ; Kaanders JH; Bussink J
Radiother Oncol; 2011 Jun; 99(3):344-8. PubMed ID: 21684617
[TBL] [Abstract][Full Text] [Related]
6. Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck.
Thierauf J; Veit JA; Grünow J; Döscher J; Weißinger S; Whiteside T; Beutner D; Quaas A; Plinkert P; Hoffmann TK; Hess J
Anticancer Res; 2016 Feb; 36(2):611-5. PubMed ID: 26851015
[TBL] [Abstract][Full Text] [Related]
7. Sodium Iodide Symporter Expression in Adenoid Cystic Carcinoma of the Head and Neck.
Gainor DL; Chute DJ; Lorenz RR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):739-44. PubMed ID: 26043070
[TBL] [Abstract][Full Text] [Related]
8. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
[TBL] [Abstract][Full Text] [Related]
10. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinoma.
Veit JA; Scheckenbach K; Schuler PJ; Laban S; Wiggenhauser PS; Thierauf J; Klussmann JP; Hoffmann TK
Anticancer Res; 2015 Mar; 35(3):1271-7. PubMed ID: 25750274
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
[TBL] [Abstract][Full Text] [Related]
13. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.
Yang L; Wang T; Zhang J; Liu Z; Wang X
Cancer Biomark; 2016 Jun; 17(2):179-85. PubMed ID: 27540976
[TBL] [Abstract][Full Text] [Related]
14. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
[TBL] [Abstract][Full Text] [Related]
15. Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.
Zhang J; Cheng Q; Zhou Y; Wang Y; Chen X
Oral Oncol; 2013 Nov; 49(11):1043-50. PubMed ID: 24035721
[TBL] [Abstract][Full Text] [Related]
16. Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma.
Jiang L; Huang S; Li W; Zhang D; Zhang S; Zhang W; Zheng P; Chen Z
Pathol Res Pract; 2012 Nov; 208(11):635-41. PubMed ID: 23089287
[TBL] [Abstract][Full Text] [Related]
17. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
[TBL] [Abstract][Full Text] [Related]
18. High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma.
Dai W; Tan X; Sun C; Zhou Q
Int J Mol Sci; 2014 May; 15(5):8393-406. PubMed ID: 24828201
[TBL] [Abstract][Full Text] [Related]
19. Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma.
Klijanienko J; el-Naggar A; Ponzio-Prion A; Marandas P; Micheau C; Caillaud JM
Arch Otolaryngol Head Neck Surg; 1993 Aug; 119(8):887-90. PubMed ID: 8393682
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.
Fukusumi T; Guo TW; Ren S; Haft S; Liu C; Sakai A; Ando M; Saito Y; Sadat S; Califano JA
Int J Oncol; 2021 Feb; 58(2):226-237. PubMed ID: 33491747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
